Flexion Therapeutics

Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on developing and commercializing novel, localized therapies for the treatment of patients with musculoskeletal conditions. The company’s approved product, ZILRETTA®, is the first and only extended-release, intra-articular or IA (i.e., within the joint) injection for the treatment of OA knee pain. ZILRETTA is a non-opioid therapy that utilizes proprietary microsphere technology to provide effective pain relief.